A Non Stimulant Drug For Oppositional Defiant Disorder That Was Just Approved By The Food And Drug Administation
A recent clinical test of the high blood pressure medication Clonicel showed that the drug significantly reduced 18 symptoms of attention-deficit/hyperactivity disorder. Researchers say Clonicel may be more effective in easing the emotional outbursts, mood swings, irritability, and sensitivity to stress sometimes associated with ADHD. A group of 228 children between the ages of 6 and 17 with ADHD participated in the eight-week study. If the Food and Drug Administration approves the medication,...
Read moreMore information on "A Non Stimulant Drug For Oppositional Defiant Disorder That Was Just Approved By The Food And Drug Administation"
From Our Experts
Deep Brain Stimulation Approved for OCD. Depression Next?
Yesterday, the FDA approved the Medtronic Reclaim Deep Brain Stimulator device for the treatment of obsessive-compulsive disorder (OCD).... Read more »
More Than Half of Antipsychotic Prescriptions Aren't for FDA-Approved...
A study at the Penn State College of Medicine says that "[r]educing the non-FDA-approved use of antipsychotic drugs may be a way to save... Read more »
Two Studies Show FDA Approved Drugs May Contribute to a Future...
Two studies published in academic journals this week have reported possible future treatment benefits for people with Alzheimer's disease... Read more »
New Drug Ampyra Approved by FDA for Multiple Sclerosis Patients
Late Friday afternoon, January 22, 2010, the Food and Drug Administration (FDA) announced that they approved AMPYRA™ (dalfampridine,... Read more »
New Drug Approved for Migraine Attacks
The FDA has approved a new prescription medication for the acute treatment of Migraine attacks, Cambia, developed by Kowa Pharmaceuticals... Read more »
From Our Sources
When Teens With ADHD Are Defiant
When a teen is defiant, the entire household suffers. Parents are often exhausted from fighting on the battleground that was once their home. Parents... Read more »
Occipital Nerve Stimulation for Migraine and Headache Preventi...
The use of occipital nerve stimulation (ONS) for the prevention of Migraines and headaches is in clinical trials and has been of great interest to... Read more »
FDA approves new TMS depression therapy
The U.S. Food and Drug Administration has approved the NeuroStar Transcranial Magnetic Stimulation (TMS) system for use in people who suffer from... Read more »
Strattera
Brand Name: Strattera Generic Name: atomoxetine hydrochloride Usage: Strattera has been approved by the Food and Drug Administration to treat... Read more »
FDA Approves Intuniv as Add-On Therapy
The U.S. Food and Drug Administration (FDA) has approved Intuniv extended-release tablets as adjunctive therapy for stimulants in kids and... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
